Table 2 Median and interquartile range of laboratory variables investigated according to outcome in patients with COVID-19

Total bilirubin (mg/dL)

0.36

[0.26–0.48]

0.36

[0.26–0.46]

0.35

[0.24–0.56]

0.541

Creatinine (mg/dL)

0.86

[0.70–1.07]

0.82

[0.66–0.99]

1.10

[0.70–2.20]

< 0.001

PTX3 concentration (ng/mL)

16.66

[5.87–37.80]

10.79

[4.93–22.93]

52.84

[23.32-106.26]

< 0.001

D-dimer (mg/L)

0.90

[0.55–2.49]

0.74

[0.51–1.38]

2.80

[1.00-7.10]

< 0.001

Blood glucose (mg/dL)

154.50

[125.00-215.75]

146.00

[118.00-189.00]

201.30

[150.00-258.00]

< 0.001

INR

1.19

[1.03–1.31]

1.23

[1.08–1.33]

1.06

[0.94–1.15]

< 0.001

Total leukocytes (absolute value/mm³)

8670

[6543–11620]

8190

[5940–10960]

10,590

[7920–14940]

< 0.001

Platelets (absolute value/mm³)

235,000

[176000 − 30875]

231,000

[175500–303500]

256,430

[179000 − 32000]

0.201

C-reactive protein (mg/L)

92.72

[50.99-183.35]

81.00

[42.88-157.35]

178.10

[92.40-264.20]

< 0.001

AST (U/L)

44.00

[28.32–63.50]

40.20

[27.00-60.50]

54.80

[38.20-71.28]

< 0.001

ALT (U/L)

42.44

[25.22-63.00]

43.80

[25.05–63.75]

35.12

[26.30-59.56]

0.317

aPTT (s)

34.2

[29.52–40.19]

36.6

[30.50–41.90]

31.01

[27.90–33.60]

< 0.001

Urea

32.30

[25.60-47.67]

30.00

[22.80–38.00]

55.90

[36.60-100.50]

< 0.001